Literature DB >> 33924938

CRISPR Interference Efficiently Silences Latent and Lytic Viral Genes in Kaposi's Sarcoma-Associated Herpesvirus-Infected Cells.

Kevin Brackett1, Ameera Mungale1, Mary Lopez-Isidro1, Duncan A Proctor1, Guillermo Najarro1, Carolina Arias1,2,3.   

Abstract

Uncovering viral gene functions requires the modulation of gene expression through overexpression or loss-of-function. CRISPR interference (CRISPRi), a modification of the CRISPR-Cas9 gene editing technology, allows specific and efficient transcriptional silencing without genetic ablation. CRISPRi has been used to silence eukaryotic and prokaryotic genes at the single-gene and genome-wide levels. Here, we report the use of CRISPRi to silence latent and lytic viral genes, with an efficiency of ~80-90%, in epithelial and B-cells carrying multiple copies of the Kaposi's sarcoma-associated herpesvirus (KSHV) genome. Our results validate CRISPRi for the analysis of KSHV viral elements, providing a functional genomics tool for studying virus-host interactions.

Entities:  

Keywords:  CRISPR-interference; KSHV; Kaposi’s sarcoma-associated herpesvirus; dCas9-KRAB; gene expression; gene silencing

Year:  2021        PMID: 33924938     DOI: 10.3390/v13050783

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  49 in total

1.  Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction.

Authors:  Jinjong Myoung; Don Ganem
Journal:  J Virol Methods       Date:  2011-03-17       Impact factor: 2.014

Review 2.  Bacterial CRISPR screens for gene function.

Authors:  Horia Todor; Melanie R Silvis; Hendrik Osadnik; Carol A Gross
Journal:  Curr Opin Microbiol       Date:  2020-12-04       Impact factor: 7.934

3.  Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression.

Authors:  Jeffrey Vieira; Patricia M O'Hearn
Journal:  Virology       Date:  2004-08-01       Impact factor: 3.616

Review 4.  KSHV Genome Replication and Maintenance.

Authors:  Pravinkumar Purushothaman; Prerna Dabral; Namrata Gupta; Roni Sarkar; Subhash C Verma
Journal:  Front Microbiol       Date:  2016-02-01       Impact factor: 5.640

5.  Optimizing sgRNA position markedly improves the efficiency of CRISPR/dCas9-mediated transcriptional repression.

Authors:  Aliaksandra Radzisheuskaya; Daria Shlyueva; Iris Müller; Kristian Helin
Journal:  Nucleic Acids Res       Date:  2016-06-28       Impact factor: 16.971

Review 6.  KSHV Entry and Trafficking in Target Cells-Hijacking of Cell Signal Pathways, Actin and Membrane Dynamics.

Authors:  Binod Kumar; Bala Chandran
Journal:  Viruses       Date:  2016-11-14       Impact factor: 5.048

7.  Epigenetic factor siRNA screen during primary KSHV infection identifies novel host restriction factors for the lytic cycle of KSHV.

Authors:  Nenavath Gopal Naik; Thomas Hong Nguyen; Lauren Roberts; Luke Todd Fischer; Katherine Glickman; Gavin Golas; Bernadett Papp; Zsolt Toth
Journal:  PLoS Pathog       Date:  2020-01-10       Impact factor: 6.823

8.  Activation of host translational control pathways by a viral developmental switch.

Authors:  Carolina Arias; Derek Walsh; Jack Harbell; Angus C Wilson; Ian Mohr
Journal:  PLoS Pathog       Date:  2009-03-20       Impact factor: 6.823

9.  Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits.

Authors:  Diego Acosta-Alvear; Min Y Cho; Thomas Wild; Tonia J Buchholz; Alana G Lerner; Olga Simakova; Jamie Hahn; Neha Korde; Ola Landgren; Irina Maric; Chunaram Choudhary; Peter Walter; Jonathan S Weissman; Martin Kampmann
Journal:  Elife       Date:  2015-09-01       Impact factor: 8.140

10.  Quantitative Proteomics Analysis of Lytic KSHV Infection in Human Endothelial Cells Reveals Targets of Viral Immune Modulation.

Authors:  Ildar Gabaev; James C Williamson; Thomas W M Crozier; Thomas F Schulz; Paul J Lehner
Journal:  Cell Rep       Date:  2020-10-13       Impact factor: 9.423

View more
  2 in total

1.  Antiviral Targeting of Varicella Zoster Virus Replication and Neuronal Reactivation Using CRISPR/Cas9 Cleavage of the Duplicated Open Reading Frames 62/71.

Authors:  Betty W Wu; Michael B Yee; Ronald S Goldstein; Paul R Kinchington
Journal:  Viruses       Date:  2022-02-12       Impact factor: 5.818

2.  A Two-tiered functional screen identifies herpesviral transcriptional modifiers and their essential domains.

Authors:  David W Morgens; Divya Nandakumar; Allison L Didychuk; Kevin J Yang; Britt A Glaunsinger
Journal:  PLoS Pathog       Date:  2022-01-18       Impact factor: 6.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.